TCR repertoire sequencing and analysis platform

Efficient identification of tumor antigen-specific TCRs is the key to TCR-T technology. TCRCure possesses world-leading technologies in T cell immunotherapies, including TCR repertoire sequencing, high-throughput sequencing-based HLA haplotyping, and high-throughput single-cell sequencing-based T cell transcriptome/repertoire analysis. TCRCure has applied for 5 invention patents, developed a proprietary TCR repertoire analysis algorithm, and formulated management documents, quality manuals and operating procedures. With these technologies, TCRCure is capable of capturing tumor antigen-specific TCRs, cloning and constructing TCR databases, building TCR-T plasmids and virus libraries for given HLA restricted tumor antigens, and providing solutions for next-generation TCR-T immunotherapy.

 

400-968-1881

Los Angeles California

Address:  5370 Alhambra Ave Ste F, Los Angeles, CA 90032, USA

 

Durham North Carolina

Address: 701 West Main St. Suite 200, Durham 27701 USA

 

 

Thank you for coming to TCRCure, if you have the intention of cooperation, please leave us a message or use the following ways to contact us, and to provide you with the most sincere professional services, thank you.

SAY HELLO!

© 2017 Chongqing TCRCure Biological Technology Co Ltd. All Rights Reserved.  渝ICP备17005995号  Powered by: www.300.cnManager